Comparing Standard Platelet-Rich Plasma and Light-Enhanced Platelet-Rich Plasma for Treating Hair Loss in Androgenetic Alopecia: A Randomized Controlled Trial

Starting soon · Early Phase 1

Conditions studied: Androgenetic Alopecia

In brief

The goal of this clinical trial is to compare 3 different types of PRP in androgenetic alopecia patients. The main questions it aims to answer: Does Redlight enhanced, Blue light enhanced, or traditional PRP result in higher hair density and health? Does Redlight enhanced, Blue light enhanced, or traditional PRP result in other improved hair metrics. Participants will consent to a PRP treatment but will be blinded to the type. They will then be asked to return for Tricholab analysis at set post-operative timepoints to record changes in hair metrics (Baseline, 1 month, 3 months, 6 months, 9 months, 12 months).

Key facts

Study ID

NCT07739147

Run by

Kimberly Meathrel

People needed

30

Starts

2026-12-30

Expected to finish

2027-12-30

Last updated by the study team

2026-07-31

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-65
• Diagnosed Androgenetic Alopecia
• Willing to comply with protocol and follow up

You may not qualify if…

• Active scalp infection or disease
• Prior PRP within last 6 months
• Use of hair growth medication topical or oral
• Platelet dysfunction or anticoagulation
• Pregnant or breastfeeding
• history of keloid infection

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.